# US 2024/0189283 A1 · L-ergothioneine-containing composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189283 A1
- Document ID: US20240189283A1
- Status: Published application
- Kind: A1
- Application number: 18/555,223
- Filed: 2022-03-30
- Published: 2024-06-13
- Earliest claimed: 2021-04-14
- Assignees: Nagase & Co., Ltd.
- Applicants: Nagase & Co., Ltd.
- Inventors: Jun Matsumoto; Takeshi Nakatani
- Web page: https://patentgrep.com/patent/US20240189283A1

## CPC

- A61K 31/417: Imidazole-alkylamines, e.g. histamine, phentolamine
- A61K 31/4172: Imidazole-alkanecarboxylic acids, e.g. histidine
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A61K 31/70: Carbohydrates; Sugars; Derivatives thereof (sorbitol A61K31/047)
- A61K 31/7028: Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61P 17/18: Antioxidants, e.g. antiradicals (preparations for protection against sunlight A61Q17/00)
- A61P 39/06: Free radical scavengers or antioxidants
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

A composition in which L-ergothioneine (EGT) and S-ribosylhomocysteine (SRH) coexist makes it is possible to suppress coloring of the composition. A composition comprising EGT and SRH is prepared in which the content of SRH is reduced.

## Claims

### Claim 1

A composition comprising L-ergothioneine and S-ribosylhomocysteine, wherein a content of the S-ribosylhomocysteine is reduced.

### Claim 2 (depends on 1)

The composition according to claim 1, wherein the content of the S-ribosylhomocysteine is reduced so that coloring of the composition is suppressed.

### Claim 3 (depends on 1)

The composition according to claim 1, wherein the content of the S-ribosylhomocysteine is 15 parts by mass or less with respect to 100 parts by mass of the L-ergothioneine.

### Claim 4 (depends on 1)

The composition according to any one of claim 1, wherein the content of the S-ribosylhomocysteine is 0.001 parts by mass or more with respect to 100 parts by mass of the L-ergothioneine.

### Claim 5

A composition comprising L-ergothioneine and S-ribosylhomocysteine and having suppressed coloring of the composition, wherein a content of the S-ribosylhomocysteine is 15 parts by mass or less with respect to 100 parts by mass of the L-ergothioneine.

### Claim 6

A method for producing a composition comprising L-ergothioneine and S-ribosylhomocysteine and having suppressed coloring, the method comprising the step of reducing a content of the S-ribosylhomocysteine.

### Claim 7

A method for imparting a coloring-suppressing effect to a composition comprising L-ergothioneine and S-ribosylhomocysteine, wherein a content of the S-ribosylhomocysteine is 15 parts by mass or less with respect to 100 parts by mass of the L-ergothioneine.
